Aim To explore breast cancer patient's perspective on future genetic testing for prediction of
toxicity after breast radiotherapy (RT). Materials and methods The study involved patient …

Genomic tumor testing (GTT) is an emerging technology aimed at identifying variants in
tumors that can be targeted with genomically matched drugs. Due to limited resources, rural …

Germline genome sequencing (GS) holds great promise for cancer prevention by identifying
cancer risk and guiding prevention strategies, however research evidence is mixed …

PURPOSE The Maine Cancer Genomics Initiative (MCGI) aimed to overcome patient-and
provider-level barriers to using genomic tumor testing (GTT) in rural practices by providing …

PURPOSE Social determinants of health, such as rurality, income, and education, may
widen health disparities by driving variation in patients' knowledge and perceptions of …

The communication of genomic results to patients and families with rare diseases raise
distinctive challenges. However, there is little evidence about optimal methods to …

Genomic Tumour Testing (GTT) is an emerging site of “experimental care” in oncology
[Cambrosio, Alberto, Peter Keating, Etienne Vignola-Gagné, Sylvain Besle, and Pascale …

Introduction Tumor genomic testing (TGT) is standard‐of‐care for most patients with
advanced/metastatic cancer. Despite established guidelines, patient education prior to TGT …

Objective To assess the presentation of risk information in American College of Obstetricians
and Gynecologists (ACOG) obstetrical Practice Bulletins. Methods We reviewed B-and C …

Clinical genetic variant classification science is a growing subspecialty of clinical genetics
and genomics. The field's continued improvement is essential for the success of precision …